Dr. Scott is a native Californian and received his medical degree at the University of California San Francisco School of Medicine. He completed his internship at the University of Minnesota Hospital and Clinic, and residencies at the University of Minnesota Hospital and Clinic (neurological surgery) and Stanford University Medical Center (ophthalmology). A founding member of the Smith-Kettlewell Eye Research Institute, he was a Senior Scientist and Co-Director for 22 of the Institute’s most productive years. He was for some years Vice-Chairman of the Department of Ophthalmology at the California Pacific Medical Center.
Dr. Scott is duly credited with introducing the use of Botulinum Toxin to Ophthalmology and the rest of Medicine. Literally, he created botulinum toxin as a product, and was the first to use it to treat strabismus, blepharospasm, torticollis, and leg spasm. Obtaining FDA approval and license for the drug, he manufactured it for 2 years, before turning it over to Allergan in order to go back to research and clinical practice.
Dr. Scott is internationally recognized as an authority in Pediatric Ophthalmology and Strabismus. Dr. Scott continues productive work both clinically and experimentally and we are extremely proud to have him as a member of our NBEA clinical team. Dr. Scott is currently seeing patients in these offices: